Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Gene Expression »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Gemtuzumab < Gene Expression < Gene Expression Profiling  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000692 (2018) Giuseppina Stifano [États-Unis] ; Thierry Sornasse [États-Unis] ; Lisa M. Rice [États-Unis] ; Leo Na [États-Unis] ; Haiyin Chen-Harris [États-Unis] ; Dinesh Khanna ; Angelika Jahreis [États-Unis] ; Yuqing Zhang [États-Unis] ; Jeff Siegel [États-Unis] ; Robert Lafyatis [États-Unis]Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis.
000988 (2017) Vatinee Y. Bunya [États-Unis] ; Simone Iwabe [États-Unis] ; Ilaria Macchi [Italie] ; Mina Massaro-Giordano [États-Unis] ; Maxwell Pistilli [États-Unis] ; Gustavo D. Aguirre [États-Unis]Tolerability of Topical Tocilizumab Eyedrops in Dogs: A Pilot Study.
000B44 (2017) Hanchao Gao [République populaire de Chine] ; Lu Liu [République populaire de Chine] ; Yanli Zhao [République populaire de Chine] ; Hidetaka Hara [États-Unis] ; Pengfei Chen [République populaire de Chine] ; Jia Xu [République populaire de Chine] ; Jia Tang [République populaire de Chine] ; Ling Wei [République populaire de Chine] ; Zesong Li [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Zhiming Cai [République populaire de Chine] ; Lisha Mou [République populaire de Chine]Human IL-6, IL-17, IL-1β, and TNF-α differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells.
000C44 (2017) Jin Nakagawa [Japon] ; Yoshinobu Koyama [Japon] ; Atsushi Kawakami [Japon] ; Yukitaka Ueki [Japon] ; Hiroshi Tsukamoto [Japon] ; Takahiko Horiuchi [Japon] ; Shuji Nagano [Japon] ; Ayumi Uchino [Japon] ; Toshiyuki Ota [Japon] ; Mitsuteru Akahoshi [Japon] ; Koichi Akashi [Japon]A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study.
001023 (2015) C. Takai ; I. Matsumoto ; A. Inoue ; N. Umeda ; Y. Tanaka ; Y. Kurashima ; Y. Wada [Japon] ; I. Narita [Japon] ; T. SumidaSpecific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
001090 (2015) Aki Isobe [Japon] ; Kenjiro Sawada [Japon] ; Yasuto Kinose [Japon] ; Chifumi Ohyagi-Hara [Japon] ; Erika Nakatsuka [Japon] ; Hiroshi Makino [Japon] ; Tomonori Ogura [Japon] ; Tomoko Mizuno [Japon] ; Noriko Suzuki [Japon] ; Eiichi Morii [Japon] ; Koji Nakamura [Japon] ; Ikuko Sawada [Japon] ; Aska Toda [Japon] ; Kae Hashimoto [Japon] ; Seiji Mabuchi [Japon] ; Tsuyoshi Ohta [Japon] ; Ken-Ichirou Morishige [Japon] ; Hirohisa Kurachi [Japon] ; Tadashi Kimura [Japon]Interleukin 6 receptor is an independent prognostic factor and a potential therapeutic target of ovarian cancer.
001322 (2014) Tamarah D. De Jong ; Saskia Vosslamber ; Cornelis L. VerweijMoving towards personalized medicine in rheumatoid arthritis.
001357 (2014) Julie Ducreux [Belgique] ; Patrick Durez ; Christine Galant ; Adrien Nzeusseu Toukap ; Benoît Van Den Eynde ; Frédéric A. Houssiau ; Bernard R. LauwerysGlobal molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
001418 (2014) Keisuke Tanaka [Japon] ; Misato Hashizume ; Masahiko Mihara ; Hiroto Yoshida ; Miho Suzuki ; Yoshihiro MatsumotoAnti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model.
001539 (2013) Aart C. Strang [Pays-Bas] ; Radjesh J. Bisoendial ; Ruud S. Kootte ; Dominik M. Schulte ; Geesje M. Dallinga-Thie ; Johannes H M. Levels ; Marc Kok ; Koen Vos ; Sander W. Tas ; Uwe J F. Tietge ; Nike Müller ; Matthias Laudes ; Danielle M. Gerlag ; Erik S G. Stroes ; Paul P. TakPro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis.
001561 (2013) Shannon Dallas [États-Unis] ; Souvik Chattopadhyay ; Carlo Sensenhauser ; Ameesha Batheja ; Monica Singer ; Jose SilvaInterleukins-12 and -23 do not alter expression or activity of multiple cytochrome P450 enzymes in cryopreserved human hepatocytes.
001606 (2013) Soken-Nakazawa J. Song ; Mitsuhiro Iwahashi ; Naohisa Tomosugi ; Kazuko Uno ; Jiro Yamana ; Seizou Yamana ; Tomoyasu Isobe ; Hiroki Ito ; Hiroshi Kawabata ; Kazuyuki YoshizakiComparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.
001A97 (2009) Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei YokotaInterleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Gene Expression" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Gene Expression" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Gene Expression
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021